Ankara City Hospital Bilkent
saglik.gov.trTotal trials
397
Active
91
Phase 3
1
Total enrollment
57,745
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 17 of 17 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Umbilical Cord-Derived Mesenchymal Stem Cells | — | — | — | — | — | 1 | |
| Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes | — | — | — | — | — | 1 | |
| Control group | — | — | — | — | — | 1 | |
| Lidocaine and Dexamethasone for PENG Block | — | — | — | — | — | 1 | |
| 5% dextrose | — | — | — | — | — | 1 | |
| Ephedrine | — | — | — | — | — | 1 | |
| Noradrenalin | — | — | — | — | — | 1 | |
| Lidocaine spray | — | — | — | — | — | 1 | |
| Rocuronium | — | — | — | — | — | 1 | |
| Etofenamat | — | — | — | — | — | 1 | |
| Diclofenac | — | — | — | — | — | 1 | |
| Dutasteride | — | — | — | — | — | 1 | |
| Bupivacain | — | — | — | — | — | 1 | |
| moderate dose Dexamethasone | — | — | — | — | — | 1 | |
| High dose dexamethasone | — | — | — | — | — | 1 | |
| Lidocaine | — | — | — | — | — | 1 | |
| Normal Saline | — | — | — | — | — | 1 |
Next readouts
- 2023-07-01
- 2024-05-01
- 2024-09-20
- 2024-10-01
- 2024-12-01
- 2026-04-01
- 2026-04-23
- 2026-07-30
- 2026-10-01
- 2026-10-01
Top conditions
- Anesthesia18
- Postoperative Pain10
- Sedation7
- Pain, Postoperative6
- Knee Osteoarthritis5
- Regional Anesthesia5
- Cardiac Surgery5
- Analgesia5
Frequently asked questions about Ankara City Hospital Bilkent
- How many clinical trials does Ankara City Hospital Bilkent have on ClinicalTrials.gov?
- Ankara City Hospital Bilkent is listed as the lead sponsor on 397 clinical trials in ClinicalTrials.gov, 91 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ankara City Hospital Bilkent's trials are in Phase 3?
- 1 of Ankara City Hospital Bilkent's trials are in Phase 3, spread across 17 active drug programs.
- What therapeutic areas does Ankara City Hospital Bilkent focus on?
- Ankara City Hospital Bilkent's most-studied conditions on ClinicalTrials.gov are Anesthesia, Postoperative Pain, Sedation, Pain, Postoperative, Knee Osteoarthritis.
- When are Ankara City Hospital Bilkent's next clinical trial readouts?
- Ankara City Hospital Bilkent has 10 upcoming primary-completion readouts tracked here; the soonest is “Lidocaine Spray Use on Patients Comfort in Undergoing Bladder Catheterization”, expected around 2023-07-01.